Literature DB >> 27152465

Microbiota-Dependent Marker TMAO is Not Associated With Decreased Myocardial Perfusion in Well-Treated HIV-Infected Patients as Assessed by 82Rubidium PET/CT.

Andreas Knudsen1, Thomas Emil Christensen, Kristina Thorsteinsson, Adam Ali Ghotbi, Philip Hasbak, Anne-Mette Lebech, Susanne Dam Nielsen, Johannes Roksund Hov, Rolf Berge, Rasmus Sejersten Ripa, Andreas Kjær, Marius Trøseid.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27152465     DOI： 10.1097/QAI.0000000000001044

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  5 in total

Review 1.  Gut microbial metabolites associated with HIV infection.

Authors:  Zheng Wang; Qibin Qi
Journal:  Future Virol       Date:  2019-05-15       Impact factor: 1.831

Review 2.  The gut microbiome and HIV-1 pathogenesis: a two-way street.

Authors:  Stephanie M Dillon; Daniel N Frank; Cara C Wilson
Journal:  AIDS       Date:  2016-11-28       Impact factor: 4.177

3.  Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection.

Authors:  Judith M Haissman; Anna K Haugaard; Sisse R Ostrowski; Rolf K Berge; Johannes R Hov; Marius Trøseid; Susanne D Nielsen
Journal:  BMC Infect Dis       Date:  2017-06-23       Impact factor: 3.090

4.  Carnitine Is Associated With Atherosclerotic Risk and Myocardial Infarction in HIV -Infected Adults.

Authors:  Arjun Sinha; Yifei Ma; Rebecca Scherzer; Smruti Rahalkar; Brendan D Neilan; Heidi Crane; Daniel Drozd; Jeffrey Martin; Steven G Deeks; Peter Hunt; Priscilla Y Hsue
Journal:  J Am Heart Assoc       Date:  2019-05-07       Impact factor: 5.501

Review 5.  Dysfunctional Immunometabolism in HIV Infection: Contributing Factors and Implications for Age-Related Comorbid Diseases.

Authors:  Tiffany R Butterfield; Alan L Landay; Joshua J Anzinger
Journal:  Curr HIV/AIDS Rep       Date:  2020-04       Impact factor: 5.071
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.